RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

Neuro - your explanations have been perfectly clear and answered all of the relevant questions pretty conclusively in this mini-discussion about the AD trial.

There are things I have some reservations about and questions over in terms of mgmt decisions, but not this one.

Had Cortex thought this was a valid avenue to pursue, factoring in all variables at each checkpoint when such a decision could have been made, clearly they would have done so.